Loading institutional data...
Loading institutional data...
Institutional ownership roughly stable: -0.28% change quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$21M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~0.5% on $20M of debt. Interest last disclosed in FY2025 (no longer broken out).
Cash of $7M is below short-term debt of $8M — relies on refinancing/operations.
Mostly long-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-08-05 · 44d old
How a revenue dollar becomes profit — FY2026
Each value shows its share of revenue below it (common-size).
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $55.0M 100.0% | $44.3M 100.0% | $46.7M 100.0% | $13.6M 100.0% | — |
| Cost of Revenue | $21.3M 38.7% | $18.8M 42.5% | $18.1M 38.8% | $5.4M 39.9% | — |
| Research & Development | $408K 0.7% | $3.8M 8.5% | $5.0M 10.6% | $2.7M 19.7% | — |
| Selling, General & Admin | $16.0M 29.0% | $51.6M 116.5% | $65.9M 141.0% | $4.6M 34.3% | $1.8M |
| Total Operating Expenses | — | $8.4M 18.9% | $3.5M 7.4% | — | $2.0M |
| Operating Income | -$14.0M -25.4% | -$60.8M -137.3% | -$77.7M -166.2% | -$11.5M -85.0% | — |
| Interest Expense | — | $100K 0.2% | — | — | — |
| Other Income (Expense), net | -$9.0M -16.4% | -$12.3M -27.7% | -$22.2M -47.6% | -$2.7M -20.0% | $3.0M |
| Pretax Income | -$23.0M -41.8% | -$73.1M -165.0% | -$99.9M -213.8% | -$14.2M -105.0% | — |
| Income Tax Expense | $20K 0.0% | -$14K -0.0% | -$24K -0.1% | -$42K -0.3% | — |
| Net Income | -$22.5M -40.9% | -$72.9M -164.5% | -$99.7M -213.3% | -$14.0M -103.4% | $983K |
| Per Share | |||||
| EPS (Basic) | $-0.29 | $-1.04 | $-2.26 | $-0.86 | — |
| EPS (Diluted) | $-0.29 | $-1.04 | $-2.26 | $-0.86 | — |
| Weighted Avg Shares (Basic) | 77.5M | 69.9M | 44.0M | 16.5M | — |
| Weighted Avg Shares (Diluted) | 77.5M | 69.9M | 44.0M | 16.5M | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
EOD close · as of 2026-08-05
Is the profit real, and how strong is the balance sheet?
FY2026 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2023 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Cost of Revenue | — | 39.9 | 38.8 | 42.5 | 38.7 |
| R&D | — | 19.7 | 10.6 | 8.5 | 0.7 |
| SG&A | — | 34.3 | 141.0 | 116.5 | 29.0 |
| Operating Income | — | -85.0 | -166.2 | -137.3 | -25.4 |
| Income Tax | — | -0.3 | -0.1 | -0.0 | 0.0 |
| Net Income | — | -103.4 | -213.3 | -164.5 | -40.9 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on RDZNW: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position